Christina Weng is an Ophthalmology physician affiliated with Baylor College of Medicine. OpenAlex indexes 195 publications with 2,157 citations (h-index 24); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1504 Taub Loop
Houston, TX 770301608
Telephone
713-526-4243Provider last certified this registry record 21 Mar 2024.
Clinical trials
- Safety, Pharmacokinetics and Efficacy of PP405 in Adults With AGA
Sponsor: Pelage Pharmaceuticals, Inc.
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
33 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year202529 payments$44,932openpaymentsdata.cms.gov ↗
- Boehringer Ingelheim International GmbHProgram year20256 payments
- Ocular Therapeutix, Inc.Program year20256 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
91.6%Antineovascularisation agents90.5%Faricimab-svoa100%Part B, office-administered≥14 patientsCorticosteroid0.9%Prednisolone Acetate100%Part D≥24 patients+ 1 more class in this area
Cancer & immunology
7.8%Vascular Endothelial Growth Factor Inhibitor7.8%Aflibercept58%Bevacizumab42%Part B, office-administered≥36 patientsMusculoskeletal
0.7%Cyclooxygenase Inhibitor0.7%Ketorolac Tromethamine100%Part D≥13 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Christie Ballantyne, MD
Baylor College of Medicine
Biykem Bozkurt, MD
Baylor College of Medicine
William Mitch, MD
Baylor College of Medicine
Garabed Eknoyan, MD
Baylor College of Medicine
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”